These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 22475274)

  • 1. Relevance of activated leukocyte cell adhesion molecule (ALCAM) in tumor tissue and sera of cervical cancer patients.
    Ihnen M; Kress K; Kersten JF; Kilic E; Choschzick M; Zander H; Müller V; Mahner S; Jänicke F; Woelber L; Milde-Langosch K
    BMC Cancer; 2012 Apr; 12():140. PubMed ID: 22475274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue.
    Hein S; Müller V; Köhler N; Wikman H; Krenkel S; Streichert T; Schweizer M; Riethdorf S; Assmann V; Ihnen M; Beck K; Issa R; Jänicke F; Pantel K; Milde-Langosch K
    Breast Cancer Res Treat; 2011 Sep; 129(2):347-60. PubMed ID: 20972617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ALCAM (CD166) expression and serum levels in pancreatic cancer.
    Tachezy M; Zander H; Marx AH; Stahl PR; Gebauer F; Izbicki JR; Bockhorn M
    PLoS One; 2012; 7(6):e39018. PubMed ID: 22745698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcellular localization of activated leukocyte cell adhesion molecule is a molecular predictor of survival in ovarian carcinoma patients.
    Mezzanzanica D; Fabbi M; Bagnoli M; Staurengo S; Losa M; Balladore E; Alberti P; Lusa L; Ditto A; Ferrini S; Pierotti MA; Barbareschi M; Pilotti S; Canevari S
    Clin Cancer Res; 2008 Mar; 14(6):1726-33. PubMed ID: 18347173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated leukocyte cell adhesion molecule (CD166)--its prognostic power for colorectal cancer patients.
    Tachezy M; Zander H; Gebauer F; Marx A; Kaifi JT; Izbicki JR; Bockhorn M
    J Surg Res; 2012 Sep; 177(1):e15-20. PubMed ID: 22482754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated leukocyte cell adhesion molecule (ALCAM/CD166) expression in head and neck squamous cell carcinoma (HNSSC).
    Clauditz TS; von Rheinbaben K; Lebok P; Minner S; Tachezy M; Borgmann K; Knecht R; Sauter G; Wilczak W; Blessmann M; Münscher A
    Pathol Res Pract; 2014 Oct; 210(10):649-55. PubMed ID: 25028217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression levels of Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) in primary breast carcinoma and distant breast cancer metastases.
    Ihnen M; Köhler N; Kersten JF; Milde-Langosch K; Beck K; Höller S; Müller V; Witzel I; Jänicke F; Kilic E
    Dis Markers; 2010; 28(2):71-8. PubMed ID: 20364042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoplasmic accumulation of activated leukocyte cell adhesion molecule is a predictor of disease progression and reduced survival in oral cancer patients.
    Sawhney M; Matta A; Macha MA; Kaur J; DattaGupta S; Shukla NK; Ralhan R
    Int J Cancer; 2009 May; 124(9):2098-105. PubMed ID: 19142865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of activated leukocyte cell adhesion molecule in the serum of breast cancer patients and implications for prognosis.
    Witzel I; Schröder C; Müller V; Zander H; Tachezy M; Ihnen M; Jänicke F; Milde-Langosch K
    Oncology; 2012; 82(6):305-12. PubMed ID: 22555284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer.
    Devis L; Moiola CP; Masia N; Martinez-Garcia E; Santacana M; Stirbat TV; Brochard-Wyart F; García Á; Alameda F; Cabrera S; Palacios J; Moreno-Bueno G; Abal M; Thomas W; Dufour S; Matias-Guiu X; Santamaria A; Reventos J; Gil-Moreno A; Colas E
    J Pathol; 2017 Mar; 241(4):475-487. PubMed ID: 27873306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated leukocyte cell adhesion molecule expression is up-regulated in the development of endometrioid carcinoma.
    Liang S; Huang C; Jia S; Wang B
    Int J Gynecol Cancer; 2011 Apr; 21(3):523-8. PubMed ID: 21430457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of ALCAM (CD166/MEMD) expression in cutaneous melanoma patients.
    Donizy P; Zietek M; Halon A; Leskiewicz M; Kozyra C; Matkowski R
    Diagn Pathol; 2015 Jul; 10():86. PubMed ID: 26134500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ALCAM (CD166) expression as novel prognostic biomarker for pancreatic neuroendocrine tumor patients.
    Tachezy M; Zander H; Marx AH; Gebauer F; Rawnaq T; Kaifi JT; Sauter G; Izbicki JR; Bockhorn M
    J Surg Res; 2011 Oct; 170(2):226-32. PubMed ID: 21816425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Significance of Activated Leukocyte Cell Adhesion Molecule (ALCAM) in Association with Promoter Methylation of the ALCAM Gene in Breast Cancer.
    Jeong YJ; Oh HK; Park SH; Bong JG
    Molecules; 2018 Jan; 23(1):. PubMed ID: 29315254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated leukocyte cell adhesion molecule expression correlates with the WNT subgroup in medulloblastoma and is involved in regulating tumor cell proliferation and invasion.
    Achiha T; Kijima N; Kodama Y; Kagawa N; Kinoshita M; Fujimoto Y; Nonaka M; Fukai J; Inoue A; Nishida N; Yamanaka T; Harada A; Mori K; Tsuyuguchi N; Uda T; Ishibashi K; Tomogane Y; Sakamoto D; Shofuda T; Yoshioka E; Kanematsu D; Mano M; Luu B; Taylor MD; Kanemura Y; Kishima H
    PLoS One; 2020; 15(12):e0243272. PubMed ID: 33270750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual knockdown of Galectin-8 and its glycosylated ligand, the activated leukocyte cell adhesion molecule (ALCAM/CD166), synergistically delays in vivo breast cancer growth.
    Ferragut F; Cagnoni AJ; Colombo LL; Sánchez Terrero C; Wolfenstein-Todel C; Troncoso MF; Vanzulli SI; Rabinovich GA; Mariño KV; Elola MT
    Biochim Biophys Acta Mol Cell Res; 2019 Aug; 1866(8):1338-1352. PubMed ID: 30905597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated leukocyte cell adhesion molecule soluble form: a potential biomarker of epithelial ovarian cancer is increased in type II tumors.
    Carbotti G; Orengo AM; Mezzanzanica D; Bagnoli M; Brizzolara A; Emionite L; Puppo A; Centurioni MG; Bruzzone M; Marroni P; Rossello A; Canevari S; Ferrini S; Fabbi M
    Int J Cancer; 2013 Jun; 132(11):2597-605. PubMed ID: 23169448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of SPR and ELISA methods based on analysis of CD166/ALCAM levels in cancer and control human sera.
    Vaisocherová H; Faca VM; Taylor AD; Hanash S; Jiang S
    Biosens Bioelectron; 2009 Mar; 24(7):2143-8. PubMed ID: 19157844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated leukocyte cell adhesion molecule: a novel biomarker for breast cancer.
    Kulasingam V; Zheng Y; Soosaipillai A; Leon AE; Gion M; Diamandis EP
    Int J Cancer; 2009 Jul; 125(1):9-14. PubMed ID: 19322904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sonic Hedgehog Signalling Activation Contributes to ALCAM Over-Expression and Poor Clinical Outcome in Patients with Oral Squamous Cell Carcinoma.
    Chen G; Yan M; Li RR; Chen WT
    Chin J Dent Res; 2018; 21(1):31-40. PubMed ID: 29507910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.